Matthew Durstenfeld

Works at

University of California Los Angeles
Assistant professor

Sources: reporter.nih.gov

Grants and prizes

National Heart, Lung, and Blood Institute
R01, Cholesterol and inflammation Lowering via BEmpedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial), R01HL164337, 2022–2027, 7 Sept 2026
National Heart, Lung, and Blood Institute
K23, Low Cardiorespiratory Fitness and Chronotropic Incompetence in HIV: Risk Factors, Cardiovascular Implications, and Exercise Training as Treatment, K23HL172699, 2024–2029, 28 Aug 2026

Sources: reporter.nih.gov